Artificial intelligence helps ALS patients preserve their voices 02:41 Federal health advisers voted overwhelmingly against ...

In the last year, the FDA has approved two new drugs for ALS, after a nearly 20-year drought of new options. The approvals ...

FDA approves much-debated Alzheimer’s drug panned by experts THE ASSOCIATED PRESS June 8, 2021 at 09:15 JST Share Tweet list Print In this 2019 photo provided by Biogen, a researcher works on ...

A panel of independent experts on Wednesday recommended the FDA reject an experimental ALS drug developed by the biotech BrainStorm Cell Therapeutics, marking another defeat for the long embattled ...

Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...

Every two weeks, Pam Jeffries settles into an armchair and waits for an infusion of a groundbreaking treatment for her memory loss. The new drug, which was approved by the FDA earlier this year ...

The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.

Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be ...

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.

For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...

Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig’s disease at a Wednesday ...